As we are inspired to take on the mantle of Innovative Drug Development
Realization is speedily dawning on us that high value lies in Abbreviated New Drug Application
The focus needs to be in getting certification, a process that involves review of existing patent information,
The process involves being caught in complex litigation, but should not constrain the efforts in creating a new formulation
The focus should be on strategic integration of development efforts at Product Identification and Selection
One should go all out to come out with breeakthrough drurg introduction, and not discover drugs only through chance observation,
The focus should be on influencing the future by getting into consolidation, especially in an era of ever changing Governnment Regulations,
The final validation would lie in being the first to benefit from Commercialization and continue to scale up the business model even beyond the 180 days period of exclusion
No comments:
Post a Comment